COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy
| Autor: | Joanna Horobin, Lee M. Krug, Richard J. Gralla, Marjorie G. Zauderer, Dean A. Fennell, Mitchell Keegan, Anna K. Nowak, Hedy L. Kindler, Paul Baas |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Chemotherapy Lung business.industry Pleural mesothelioma medicine.medical_treatment respiratory system Placebo medicine.disease_cause Asbestos respiratory tract diseases Double blind Pemetrexed medicine.anatomical_structure Maintenance therapy Internal medicine Medicine business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 32:TPS7611-TPS7611 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | TPS7611 Background: Malignant pleural mesothelioma (MPM) is an aggressive tumor in the pleural lining of the lung usually caused by asbestos exposure. Median OS following frontline chemotherapy wit... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|